Human G-protein-coupled formyl peptide receptor-like 1 and its mouse homologue formyl peptide receptor 2 mediate the chemotactic activity of a variety of pathogen and host-derived peptides, including amyloid β 42 , a key causative factor in Alzheimer's disease (AD).Here, we found that polyinosine-polycytidylic acid (Poly(I:C)), which is a specific TLR3 ligand, and Imiquimod (R837), which is a specific TLR7 ligand, when used alone, each increased MAPK-dependent functional mFPR2 expression in microglial cells, and the combination of Poly(I:C) and R837 exhibited additive effect by enhancing the level of IκB-α phosphorylation. Our results indicated that RNA virus infection may actively participate in the pathogenic processes of brain inflammation and neurodegenerative diseases by TLR3-and TLR7-mediated TRIF-dependent and MyD88-dependent signaling pathways.
Introduction
Microglia are cells of the myeloid origin populating the CNS during embryogenesis where they become resident innate immune cells. As a type of tissue macrophages, microglia form the first line of defense against invading pathogens and provide a key link between the CNS and the immune system (Rock et al., 2004; Monsonego and Weiner, 2003) . In the normal brain, microglia exist in a quiescent state, but they are rapidly activated in response to injury and infection by bacteria or viruses. In the event of encephalitis caused by bacterial or viral invasion, microglia secrete acute-phase reactants and proinflammatory cytokines such as TNF-α, IL-6, and IL-12, which may aid in the clearance of the pathogen, but potentially at the cost of inflammation-associated damage to brain tissues (Nelson et al., 2002) In addition, activation of microglia is a key component seen in the pathogenesis of degenerative CNS diseases, including Alzheimer's disease (AD), Parkinson's disease (Nelson et al., 2002; Le et al., 2001 ) and prion disease (Kovacs and Budka, 2008) .
Detection and response to microbial infection by the immune system depends to a considerable extent on the family of Toll-like receptors (TLRs), evolutionarily conserved to recognize pathogenassociated molecular patterns (PAMPs) including Gram-positive andnegative bacteria, DNA and RNA viruses, fungi and protozoa, as well as some host-derived "endogenous agonists" produced in inflammatory responses (Chen et al., 2007a,b) . Human microglia express almost all TLRs identified so far, including TLR2 and TLR3 at high levels, TLR1, TLR4, TLR5, TLR6, TLR7 and TLR8 at moderate levels and TLR9 at low but detectable levels (Bsibsi et al., 2002) . Mouse microglia express TLRs 1, 2, 3, 4, 6, 7, 8 and 9, but not TLR5 (McKimmie and Fazakerley, 2005) . Although most TLRs signal through the adaptor protein MyD88, TLR3 has been shown to trigger its signaling cascade through TRIF, independent of MyD88 (Chen et al., 2007a,b) . Activation of TLRs converts microglial cells into potent mediators of CNS inflammation and anti-microbial responses by enhancing the transcription of a number of genes coding for cytokines and receptors crucial for host defense. Among such molecules up-regulated by several TLR agonists is a G-protein-coupled formyl peptide receptor mFPR2, a homologue of human FPRL1, which recognizes bacterial and host-derived chemotactic agonist peptides, including Gram-bacterial formyl peptides (Le et al., 2002) , peptides released by damaged cells (Gao et al., 2007) 
